Both in Biotechnology
LENZ Therapeutics vs Neumora Therapeutics
Over the past year LENZ returned −91.4% and NMRA returned −61.5%; their daily moves had a correlation of 0.06.
LENZ −91.4% NMRA −61.5%Growth of $1, one year, split-adjusted
| Metric | LENZ | NMRA |
|---|---|---|
| Price | $3.86 | $0.6776 |
| Market cap | $121.3M | $127.3M |
| Today | −2.53% | −2.05% |
| 1 month | −24.5% | −51.3% |
| 6 months | −53.4% | −64.9% |
| Year to date | −75.9% | −62.1% |
| 1 year | −90.8% | −61.1% |
| Revenue growth (YoY) | +9.7% | — |
| Gross margin | 94.9% | — |
| Net margin | −581.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | $220.0M | $63.9M |
| Dividend yield | — | — |
| Volatility (60d) | 71.0% | 78.4% |
| Short % of float | 75.5% | 8.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).